|
Index of reports
> Serious Reactions (1055)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin serious reactions. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 1055 Next >>
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 90.6 kg (199.3 pounds)
Reactions: Rash, Sensorimotor Disorder
Drug(s) suspected as cause:
Investigational Drug (Unspecified)
Dosage: 2 df, qd
Administration route: Oral
Start date: 2012-01-19
End date: 2012-03-13
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
Placebo
Dosage: 1 df, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
GS-5885
Dosage: 3 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
Investigational Drug (Unspecified)
Dosage: 2 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-29
End date: 2012-01-18
Ribavirin
Dosage: 600 mg, bid
Administration route: Oral
Start date: 2011-01-19
End date: 2012-03-13
GS-5885
Dosage: 3 df, qd
Administration route: Oral
Start date: 2012-01-19
End date: 2012-03-13
Peginterferon Alfa-2A
Dosage: 180 microgram, qw
Indication: Hepatitis C
Start date: 2012-01-19
End date: 2012-03-09
Other drugs received by patient: Metoprolol Tartrate; Celexa; Codeine Sulfate; Sulindac; Zithromax; Tylenol; Aspirin; Ranitidine
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from Russian Federation on 2012-08-27
Patient: female
Reactions: Tooth Extraction, Oedema, Dental Care
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-08-16
End date: 2012-06-29
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-16
End date: 2012-06-29
Other drugs received by patient: Tmc435
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: , weighing 117.9 kg (259.4 pounds)
Reactions: Abscess Rupture, Peritonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-08-01
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Start date: 2012-01-20
End date: 2012-05-18
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-05-18
Pegasys
Dosage: 180 a?g, unk
Indication: Hepatitis C
Start date: 2011-07-18
End date: 2012-05-18
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-08
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-07
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male, weighing 90.7 kg (199.5 pounds)
Reactions: Fatigue, Wrist Fracture, Diarrhoea, Liver Function Test Abnormal, Anaemia, Haemorrhoids, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 1000 mg, bid
Administration route: Oral
Indication: Hepatitis C
End date: 2012-07-01
VX-950
Dosage: unk
Administration route: Oral
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-01
End date: 2011-10-01
Pegasys
Dosage: 180 unk, unk
Indication: Hepatitis C
End date: 2012-07-01
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Rash, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-21
Ribavirin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-05-22
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-21
End date: 2012-04-03
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-27
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-17
Ribavirin
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-04-23
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-15
Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate
Possible Ribavirin side effects in male
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-27
Patient: male, weighing 61.5 kg (135.3 pounds)
Reactions: Occult Blood, Anaemia, Faeces Discoloured
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2009-02-01
End date: 2009-04-07
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2008-08-01
End date: 2009-04-07
Other drugs received by patient: Sirolimus
Possible Ribavirin side effects in male
Reported by a pharmacist from United States on 2012-08-27
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Swelling Face, Neutropenia, Rash Pruritic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-01
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Ribavirin
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-01
Possible Ribavirin side effects in male
Reported by a physician from France on 2012-08-27
Patient: male, weighing 71.0 kg (156.2 pounds)
Reactions: Neutropenia
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatitis C
VX-950
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Peginterferon Alfa-2A
Indication: Hepatitis C
Other drugs received by patient: Dexeryl
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Night Sweats, Body Temperature Increased, Anaemia, Ascites, Dysgeusia, Insomnia, Blood Uric Acid Increased, Oedema Peripheral, Sinusitis
Drug(s) suspected as cause:
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-20
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-20
End date: 2012-02-12
Pegasys
Dosage: 180 a?g, unk
Indication: Hepatitis C
Start date: 2011-11-20
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: male
Reactions: Drug Ineffective, Diabetes Mellitus, Urinary Tract Infection, Musculoskeletal Stiffness, Diabetic Complication, Influenza Like Illness
Drug(s) suspected as cause:
Pegasys
Indication: Product Used FOR Unknown Indication
Start date: 2006-02-08
End date: 2006-06-16
Ribavirin
Indication: Product Used FOR Unknown Indication
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-08-27
Patient: female
Reactions: Abscess Limb
Drug(s) suspected as cause:
Interferon
Indication: Hepatitis C
Incivek
Administration route: Oral
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Possible Ribavirin side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-24
Patient: female
Reactions: Back Pain, Oedema Peripheral, Headache
Drug(s) suspected as cause:
VX-950
Dosage: 750 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-01
End date: 2012-07-22
Ribavirin
Dosage: dosage form: unspecified
Indication: Hepatitis C
Start date: 2012-05-01
PEG-Intron
Dosage: dosage form: unspecified
Indication: Hepatitis C
Start date: 2012-05-01
Possible Ribavirin side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 61 year old male
Reactions: Retinopathy
Drug(s) suspected as cause:
VX-950
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-08-01
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-05
End date: 2012-08-01
Peginterferon Alfa-2B
Indication: Hepatitis C
Start date: 2012-05-09
Ribavirin
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-09
End date: 2012-06-04
Peginterferon Alfa-2B
Dosage: 60 a?g/kg, unk
Start date: 2012-06-21
End date: 2012-07-26
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-08-02
End date: 2012-08-07
Other drugs received by patient: Acetaminophen; Magmitt; Epinastine Hydrochloride; Gaster / 00661201 /; Acetaminophen
Possible Ribavirin side effects in female
Reported by a physician from United States on 2012-08-24
Patient: female
Reactions: Maternal Exposure During Pregnancy, Abortion Spontaneous, Pregnancy
Drug(s) suspected as cause:
Ribavirin
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Spain on 2012-08-24
Patient:
Reactions: Neutropenic Colitis, Caecitis
Drug(s) suspected as cause:
Ribavirin
Indication: Hepatic Cirrhosis
Ribavirin
Dosage: 1200 mg, qd
Indication: Hepatitis C
Start date: 2011-12-01
Boceprevir
Indication: Hepatic Cirrhosis
Boceprevir
Dosage: 800 mg, tid
Indication: Hepatitis C
Start date: 2011-12-01
End date: 2011-12-01
Peginterferon Alfa-2A
Dosage: 180 ?g, qw
Start date: 2011-12-01
Possible Ribavirin side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Periorbital Oedema, Syncope, Anaemia, Platelet Count Decreased, Dizziness, Rash, Asthenia
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-05
Ribavirin
Dosage: 200 mg, qd
Start date: 2012-08-08
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-05
Pegasys
Dosage: 90 a?g/kg, unk
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
Other drugs received by patient: Vitamin E BAR; Hydroxyzine HCL; Escitalopram; Femring MIS; Vitamin D; Progesterone; Lexapro; Ascorbic Acid
Possible Ribavirin side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: male, weighing 85.5 kg (188.0 pounds)
Reactions: Pemphigus, Stevens-Johnson Syndrome
Drug(s) suspected as cause:
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-25
End date: 2012-07-01
Incivek
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-25
End date: 2012-07-01
Pegasys
Indication: Hepatitis C
Start date: 2012-06-25
End date: 2012-07-01
Losartan Potassium
Dosage: 50 mg, qd
Administration route: Oral
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-24
Patient:
Reactions: Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Monocytosis, Pyrexia, Proteinuria, Hypoalbuminaemia, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Interferon Beta NOS
Dosage: 6 million iu, qd
Indication: Hepatitis C
Start date: 2011-01-26
End date: 2011-02-09
Interferon Beta NOS
Dosage: 6 million iu, tiw
Start date: 2011-02-11
Ribavirin
Dosage: 600 mg, qd 200 mg in the morning and 400 mg in the evening
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-01-26
Other drugs received by patient: Paxil; Amoban; Teprenone; Urso 250; Lorfenamin
Possible Ribavirin side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 67 year old female
Reactions: Nausea, Anaemia, Platelet Count Decreased, Blood Creatinine Increased, Hyperuricaemia, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.94 a?g/kg, unk
Start date: 2012-04-06
End date: 2012-04-26
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-16
End date: 2012-04-19
VX-950
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-04-13
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-20
End date: 2012-08-02
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-03-30
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-24
End date: 2012-03-22
PEG-Intron
Dosage: 1.13 a?g/kg, unk
Start date: 2012-04-27
End date: 2012-05-10
VX-950
Dosage: 2250 mg, qd
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-02-23
PEG-Intron
Dosage: 1.3 a?g/kg, unk
Start date: 2012-05-11
End date: 2012-08-02
PEG-Intron
Dosage: 1.5 a?g/kg, unk
Indication: Hepatitis C
Start date: 2012-02-17
End date: 2012-03-29
PEG-Intron
Start date: 2012-05-11
Other drugs received by patient: Diovan; Urso / 00465701 /; Innolet; Amlodipine
Possible Ribavirin side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 69 year old female
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 80 unk, unk
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-02-21
Ribavirin
Dosage: 400 unk, qd
Administration route: Oral
Start date: 2012-06-29
End date: 2012-07-26
Ribavirin
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-02-21
End date: 2012-03-05
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-05-04
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-02-20
Ribavirin
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-03-06
End date: 2012-06-28
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-03-22
Peginterferon Alfa-2B
Dosage: 50 a?g, unk
Start date: 2012-02-28
End date: 2012-07-27
Other drugs received by patient: Urso / 00465701 /; Mucosta; Famotidine; Marzulene-S
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient:
Reactions: White Blood Cell Count Decreased, Dyspnoea, Pruritus Generalised, Fatigue, Dysphonia, Depressed Mood, RED Blood Cell Count Abnormal, Cough
Drug(s) suspected as cause:
Victrelis
Dosage: 4 df, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-10-01
Pegasys
Dosage: 180 microgram, unk
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 200 mg, tid
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Pravastatin Sodium; Ambien; Prozac; Vitamin D; Trazodone HCL; Cholecalciferol; Levoxyl; Epoetin Alfa; Neupogen
Possible Ribavirin side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 54 year old female
Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-22
End date: 2012-05-08
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-28
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-06-12
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-19
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-20
End date: 2012-07-31
Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin
Possible Ribavirin side effects in 69 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 69 year old female
Reactions: White Blood Cell Count Decreased, Haemoglobin Decreased
Drug(s) suspected as cause:
Peginterferon Alfa-2B
Dosage: 80 unk, unk
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-02-21
Peginterferon Alfa-2B
Dosage: 50 unk, unk
Start date: 2012-02-28
End date: 2012-07-27
Ribavirin
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-03-06
End date: 2012-06-28
Ribavirin
Dosage: 400 unk, qd
Administration route: Oral
Start date: 2012-06-29
End date: 2012-07-26
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-02-20
Ribavirin
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-02-21
End date: 2012-03-05
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-03-22
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-23
End date: 2012-05-04
Other drugs received by patient: Mucosta; Marzulene-S; Urso / 00465701 /; Famotidine
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, non-Consummation, Fatigue, Malaise, RED Blood Cell Count Decreased, White Blood Cell Count Decreased, Vein Disorder, Vomiting, Nausea, Anaemia, Hypoaesthesia, Mental Impairment, Diarrhoea, Alopecia, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-09-08
End date: 2012-08-09
Ribavirin
Dosage: unk unk, unknown
Start date: 2011-09-08
End date: 2012-08-09
Other drugs received by patient: Telaprevir
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Neutrophil Count Decreased
Drug(s) suspected as cause:
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-01-21
End date: 2011-02-03
PEG-Intron
Dosage: 100 ?g, qw
Indication: Hepatitis C
Start date: 2011-02-04
Ribavirin
Dosage: 400 mg, bid
Administration route: Oral
Start date: 2011-02-04
Interferon Beta NOS
Dosage: 3 million iu, bid,6 days a week
Indication: Hepatitis C
Start date: 2011-01-21
End date: 2011-02-03
Other drugs received by patient: Candesartan Cilexetil; Lorfenamin; Norvasc; Urso 250; Lorfenamin
Possible Ribavirin side effects in
Reported by a individual with unspecified qualification from France on 2012-08-23
Patient:
Reactions: Mass, Acute Respiratory Distress Syndrome, Glomerulonephropathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ribavirin
Dosage: 800 mg, qd
Indication: Hepatitis C
Start date: 2011-11-15
Boceprevir
Dosage: 2400 mg, qd
Indication: Hepatitis C
Start date: 2011-12-13
End date: 2012-07-28
Peginterferon Alfa-2B
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2011-11-15
End date: 2012-07-28
Acetaminophen
Dosage: 1000 mg, qd
Indication: Influenza Like Illness
Start date: 2011-11-15
Truvada
Dosage: 1 df, qod
Indication: HIV Infection
Start date: 2007-01-23
Other drugs received by patient: Reyataz; Crestor; Levocarnil; Neorecormon; Sertraline Hydrochloride; Tamsulosin Hydrochloride; Plavix; Norvir; Crestor; Dexeryl Tablets
Possible Ribavirin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Surgery, Adverse Drug Reaction
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg, q8h
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Pegasys
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, q8h
Start date: 2012-07-16
End date: 2012-07-01
Possible Ribavirin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient:
Reactions: Migraine, Vomiting, Nausea, Anaemia, Deafness, Hyperhidrosis, Diarrhoea, Anger, Depression, Blindness
Drug(s) suspected as cause:
Ribavirin
Dosage: 1200 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-14
Victrelis
Dosage: 800 mg, q8h
Indication: Hepatitis C
Start date: 2012-01-05
Pegasys
Dosage: 180 ?g, unk
Indication: Hepatitis C
Start date: 2011-12-14
Other drugs received by patient: Eprex; Valium
Possible Ribavirin side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-14
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-20
End date: 2012-06-25
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-03-28
End date: 2012-04-03
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-05-01
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-07
End date: 2012-02-28
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-13
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-05-08
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-03
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-09
End date: 2012-05-22
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Start date: 2012-02-07
PEG-Intron
Dosage: 1.0 ?g/kg, qw
End date: 2012-07-03
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-23
End date: 2012-06-19
Other drugs received by patient: Epadel; Sodium Ferrous Citrate; Aspirin; Acarbose; Carvedilol; Sitagliptin Phosphate; Amlodipine Besylate; Carvedilol; Predonine; Claritin Reditabs; Dogmatyl; Livalo
Page 1 Next >>
|
